{"schema":"hottub-news/prospects/v1","item":{"id":"n_czk6phh2kzb2j3mzfwgq","title":"FDAがGLP-1製剤の「非動脈炎性前部虚血性視神経症」リスク追記を要請","title_en":null,"url":"https://medical.nikkeibp.co.jp/leaf/mem/pub/hotnews/int/202611/595230.html","outlet":"medical.nikkeibp.co.jp","published":"2026-11-11T15:00:00Z","sponsored":false,"page":"https://hottub.news/articles/n_czk6phh2kzb2j3mzfwgq"},"prospects":[{"name":"日経メディカル Online","kind":"person","role":"reporter","company":"medical.nikkeibp.co.jp","website":"https://medical.nikkeibp.co.jp/","source":"https://medical.nikkeibp.co.jp/leaf/mem/pub/hotnews/int/202611/595230.html","note":"Wrote: FDAがGLP-1製剤の「非動脈炎性前部虚血性視神経症」リスク追記を要請","reason":"Reporter at medical.nikkeibp.co.jp; wrote “FDAがGLP-1製剤の「非動脈炎性前部虚血性視神経症」リスク追記を要請” on 2026-11-11","group":"Reporters","add_url":"https://crm.joinhottub.com/relationships/add#name=%E6%97%A5%E7%B5%8C%E3%83%A1%E3%83%87%E3%82%A3%E3%82%AB%E3%83%AB%20Online&company=medical.nikkeibp.co.jp&website=https%3A%2F%2Fmedical.nikkeibp.co.jp%2F&source=https%3A%2F%2Fmedical.nikkeibp.co.jp%2Fleaf%2Fmem%2Fpub%2Fhotnews%2Fint%2F202611%2F595230.html&note=Wrote%3A%20FDA%E3%81%8CGLP-1%E8%A3%BD%E5%89%A4%E3%81%AE%E3%80%8C%E9%9D%9E%E5%8B%95%E8%84%88%E7%82%8E%E6%80%A7%E5%89%8D%E9%83%A8%E8%99%9A%E8%A1%80%E6%80%A7%E8%A6%96%E7%A5%9E%E7%B5%8C%E7%97%87%E3%80%8D%E3%83%AA%E3%82%B9%E3%82%AF%E8%BF%BD%E8%A8%98%E3%82%92%E8%A6%81%E8%AB%8B","propose":{"name":"日経メディカル Online","kind":"person","reason":"Reporter at medical.nikkeibp.co.jp; wrote “FDAがGLP-1製剤の「非動脈炎性前部虚血性視神経症」リスク追記を要請” on 2026-11-11","requestId":"news:n_czk6phh2kzb2j3mzfwgq:Reporter:e94291ed:f6e92f08","company":"medical.nikkeibp.co.jp","website":"https://medical.nikkeibp.co.jp/","sourceUrl":"https://medical.nikkeibp.co.jp/leaf/mem/pub/hotnews/int/202611/595230.html"}},{"name":"medical.nikkeibp.co.jp","kind":"organization","role":"outlet","website":"https://medical.nikkeibp.co.jp/","source":"https://medical.nikkeibp.co.jp/leaf/mem/pub/hotnews/int/202611/595230.html","note":"Published: FDAがGLP-1製剤の「非動脈炎性前部虚血性視神経症」リスク追記を要請 (2026-11-11)","reason":"Published “FDAがGLP-1製剤の「非動脈炎性前部虚血性視神経症」リスク追記を要請” on 2026-11-11","group":"Outlet","add_url":"https://crm.joinhottub.com/relationships/add#name=medical.nikkeibp.co.jp&kind=organization&website=https%3A%2F%2Fmedical.nikkeibp.co.jp%2F&source=https%3A%2F%2Fmedical.nikkeibp.co.jp%2Fleaf%2Fmem%2Fpub%2Fhotnews%2Fint%2F202611%2F595230.html&note=Published%3A%20FDA%E3%81%8CGLP-1%E8%A3%BD%E5%89%A4%E3%81%AE%E3%80%8C%E9%9D%9E%E5%8B%95%E8%84%88%E7%82%8E%E6%80%A7%E5%89%8D%E9%83%A8%E8%99%9A%E8%A1%80%E6%80%A7%E8%A6%96%E7%A5%9E%E7%B5%8C%E7%97%87%E3%80%8D%E3%83%AA%E3%82%B9%E3%82%AF%E8%BF%BD%E8%A8%98%E3%82%92%E8%A6%81%E8%AB%8B%20%282026-11-11%29","propose":{"name":"medical.nikkeibp.co.jp","kind":"organization","reason":"Published “FDAがGLP-1製剤の「非動脈炎性前部虚血性視神経症」リスク追記を要請” on 2026-11-11","requestId":"news:n_czk6phh2kzb2j3mzfwgq:Outlet:7db88795:49be4448","website":"https://medical.nikkeibp.co.jp/","sourceUrl":"https://medical.nikkeibp.co.jp/leaf/mem/pub/hotnews/int/202611/595230.html"}}],"someone_else":{"source":"https://medical.nikkeibp.co.jp/leaf/mem/pub/hotnews/int/202611/595230.html","note":"In the news: FDAがGLP-1製剤の「非動脈炎性前部虚血性視神経症」リスク追記を要請 (medical.nikkeibp.co.jp, 2026-11-11)"},"crm":{"name":"CRM by Hottub","add":"Open add_url in a browser: CRM by Hottub's add form, filled in. Nothing is saved until the person presses Add.","mcp":"https://crm.joinhottub.com/api/crm/mcp","tool":"propose_relationship","propose":"If you're connected to CRM by Hottub's MCP server with proposal access, call propose_relationship with `propose` as its arguments. An owner approves it before anything is added. Keep the arguments as given: retries reuse requestId."}}